88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

< Previous page

WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards DUNDALK, Ireland , June 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its Ireland site ... 2026-06-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Classico Pokemon Collection: "Stay with Your Favorite Pokemon Everywhere" TOKYO , June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian region, including ... 2026-06-08T Health Care/Hospital Household/Consumer/Cosmetics Medical Equipment Medical/Pharmaceuticals
Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals SEOUL, South Korea , June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and ... 2026-06-08T Health Care/Hospital Medical/Pharmaceuticals
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA) SEOUL, South Korea , June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of ... 2026-06-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China SHANGHAI , June 8, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-06-08T Health Care/Hospital Medical/Pharmaceuticals
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program SAN DIEGO , June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global ... 2026-06-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39 HONG KONG , June 8, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes Association (ADA) 2026 Scientific ... 2026-06-08T Health Care/Hospital Medical/Pharmaceuticals
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma SHANGHAI , June 8, 2026 /PRNewswire/ -- OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , annou nced that its proprietary GPC3-targeted autologous CAR-T therapy, ... 2026-06-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance SHANGHAI and HONG KONG , June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-06-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved